Molina JR - Search Results

1

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.

Duma N, Kothadia SM, Azam TU, Yadav S, Paludo J, Vera Aguilera J, Gonzalez Velez M, Halfdanarson TR, Molina JR, Hubbard JM, Go RS, Mansfield AS, Adjei AA. Duma N, et al. Among authors: molina jr. Oncologist. 2019 Jan;24(1):96-102. doi: 10.1634/theoncologist.2017-0687. Epub 2018 Nov 9. Oncologist. 2019. PMID: 30413668 Free PMC article.

2

The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.

Molina JR, Adjei AA. Molina JR, et al. Clin Lung Cancer. 2003 Jul;5(1):21-7. doi: 10.3816/CLC.2003.n.017. Clin Lung Cancer. 2003. PMID: 14596699 Review.

3

Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution.

Giordano KF, Jatoi A, Adjei AA, Creagan ET, Croghan G, Frytak S, Jett JR, Marks R, Molina J, Okuno S, Richardson RL. Giordano KF, et al. Among authors: molina j. Lung Cancer. 2005 Aug;49(2):209-15. doi: 10.1016/j.lungcan.2005.01.009. Epub 2005 Apr 13. Lung Cancer. 2005. PMID: 16022915

4

A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer.

Molina JR, Nikcevich D, Hillman S, Geyer S, Drevyanko T, Jett J, Verdirame J, Tazelaar H, Rowland K, Wos E, Kutteh L, Nair S, Fitch T, Flynn P, Stella P, Adjei AA. Molina JR, et al. Cancer Invest. 2006 Jun-Jul;24(4):382-9. doi: 10.1080/07357900600705318. Cancer Invest. 2006. PMID: 16777690 Clinical Trial.

5

Advances in chemotherapy of non-small cell lung cancer.

Molina JR, Adjei AA, Jett JR. Molina JR, et al. Chest. 2006 Oct;130(4):1211-9. doi: 10.1378/chest.130.4.1211. Chest. 2006. PMID: 17035458 Review.

6

The Ras/Raf/MAPK pathway.

Molina JR, Adjei AA. Molina JR, et al. J Thorac Oncol. 2006 Jan;1(1):7-9. J Thorac Oncol. 2006. PMID: 17409820 Free article. Review. No abstract available.

7

Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors.

Haluska P, Shaw HM, Batzel GN, Yin D, Molina JR, Molife LR, Yap TA, Roberts ML, Sharma A, Gualberto A, Adjei AA, de Bono JS. Haluska P, et al. Among authors: molina jr. Clin Cancer Res. 2007 Oct 1;13(19):5834-40. doi: 10.1158/1078-0432.CCR-07-1118. Clin Cancer Res. 2007. PMID: 17908976 Clinical Trial.

8

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.

Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Molina JR, et al. Mayo Clin Proc. 2008 May;83(5):584-94. doi: 10.4065/83.5.584. Mayo Clin Proc. 2008. PMID: 18452692 Free PMC article. Review.

9

Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial data.

Molina JR, Kaufmann SH, Reid JM, Rubin SD, Gálvez-Peralta M, Friedman R, Flatten KS, Koch KM, Gilmer TM, Mullin RJ, Jewell RC, Felten SJ, Mandrekar S, Adjei AA, Erlichman C. Molina JR, et al. Clin Cancer Res. 2008 Dec 1;14(23):7900-8. doi: 10.1158/1078-0432.CCR-08-0415. Clin Cancer Res. 2008. PMID: 19047120 Free PMC article. Clinical Trial.

10

Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials.

Foster NR, Qi Y, Shi Q, Krook JE, Kugler JW, Jett JR, Molina JR, Schild SE, Adjei AA, Mandrekar SJ. Foster NR, et al. Among authors: molina jr. Cancer. 2011 Mar 15;117(6):1262-71. doi: 10.1002/cncr.25526. Epub 2010 Oct 19. Cancer. 2011. PMID: 20960500 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters